In 2017, California enacted a law that allows terminally-ill individuals to ask pharmaceutical companies to allow them to access experimental drugs that have not yet been approved for public consumption.
The idea behind the law is simple, the drug trial and approval process is long and arduous and many of the patients that may benefit from the drugs in question may die well before the drug is approved for the public. Therefore, it allows drug companies to provide access to experimental drugs, if the company so chooses, to terminally ill patients prior to Food and Drug Administration (the FDA) approval and without opening itself up to liability in the event the drug causes the patient to die earlier.
Much like legalization of marijuana, however, there are federal rules that govern access to experimental medications that cannot be trumped by state law and drug companies that allow access to experimental medications risk having their drugs denied approval if a patient outside of the regular clinical trial process has an adverse reaction or dies from the medication.
As development of these medications and conduct of drug trials is expensive, drug companies are loathe to risk drug approval for one desperate patient and often decline to allow access outside of the clinical trial.
President Trump has come out in support of a national “Right to Try” law that would allow drug companies to provide access to terminally ill patients without risking any ongoing clinical trial.
Versions of the law have been floated and one that passed the Senate last year prohibited the FDA from using patient outcomes from a “Right to Try” situation in determining whether to approve a drug, unless it was critical to determining a drug’s safety.
The drug approval process is stringent for a reason. As dangerous drugs sometimes end up with FDA approval, how many would be on the market without the oversight that is currently in place? But for people with no other options who are facing death, the possibility that their lives could even be extended for a little while overcomes any fear they may have about a drug’s lack of testing.
“Regardless of how much testing is required, sometimes drugs end up on the market that cause people injury and sometimes death. The testing conducted by the FDA is critical,” said Scott Glovsky, a Pasadena Dangerous Drug Lawyer. “However, terminally ill individuals that may benefit from a drug in testing should have the opportunity to access those medications, provided they understand all of the possible consequences. Even a small extension on life can be a huge benefit.”
Tour the secluded and quiet Bellevue Forest with its local parks, trails, forested areas and more in Neighborhood Spotlight.
In loving memory of William Dinwiddie Tucker, who passed away in 2023 at the age of 95.
Good Friday evening, Arlington. Today we published articles that were read a total of 6626 times… so far. 📈 Top stories The following are the most-read articles for today —…
Meeting for lunch? Starting Monday, January 30 and running until Friday, February 3, Copperwood Tavern, The Pinemoor, and Brass Rabbit Pub will be offering buy one, get one free soups, salads, sandwiches, and…
St. Charles offers a play-based curriculum in a welcoming, Christ-centered environment.
Our program focuses on socio-emotional development and kindergarten readiness through hands-on and engaging activities. Our programs offer different schedules ranging from 7:30 am-5:30 pm for students, ages 2-5. We feature a full-day Jr. kindergarten class for older 4’s/5’s. Our facility includes a full-sized gymnasium, school chapel, and library. All of our students enjoy music and physical education weekly. Children have an opportunity to participate in enrichment classes such as soccer, basketball, ballet, and science.
We offer Summer Camp with weekly themes and twice a week water play, including Fun Friday moon bounce. Please join us for our Open House Feb. 3 at 9:30 am and 11:00 am. Click here to sign-up.
For more information or to schedule a tour, visit us at www.stcharlesarlington.org or call (703) 527-0608.
If you are a lifelong learner over 50+ who wants to make new friends, power up your brain, and enjoy a wide-variety college-level courses, Encore Learning is for you. An Arlington based nonprofit, Encore Learning offers courses in the arts, theater, literature, history, technology and more. This semester we offer our most popular course, Global Hot Spots as well as 25 new courses. Courses are presented either online or in-person at George Mason University at Virginia Square and other Arlington locations.
Join the free presentation to learn about courses and meet the instructors. This is Encore Learning’s signature event to highlight the upcoming semester with brief presentations by each instructor.
The Spring Course Preview event is Thursday, February 2nd at 9:30 AM via Zoom:
The truth, your first pregnancy and new mom months are full of twists and turns, ups and downs, and lots of questions! None of us really know the best way to do it – we just figure it out, together…